Axsome Therapeutics (AXSM) CAPEX/Revenue US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
CAPEX/Revenue, % 1.40% 0.22%   0.09%  
Changes by years, y/y, % -1pp     -84.7%

Axsome Therapeutics. CAPEX/Revenue, %

Created with Highcharts 6.0.61.41.40.20.20.10.120222023LTM00.250.50.7511.251.5smart-lab.ru

Axsome Therapeutics. CAPEX/Revenue, changes, pp

Created with Highcharts 6.0.6-1.2-1.2-0.1-0.12023LTM-1.25-1-0.75-0.5-0.250smart-lab.ru

Axsome Therapeutics (AXSM) CAPEX/Revenue US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
CAPEX/Revenue, % 0.64% 0.01% 0.13% 0.06% 0.14%   0.09%
Changes by years, y/y, % +0pp -1pp +0pp 0pp 0pp    
Changes by quarters, q/q, % +0pp -1pp +0pp 0pp +0pp    

Axsome Therapeutics. CAPEX/Revenue, %

Created with Highcharts 6.0.62.72.72.72.70.40.40.70.70.10.10.30.30.60.60.00.00.10.10.10.10.10.12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q300.511.522.53smart-lab.ru

Axsome Therapeutics. CAPEX/Revenue, changes, pp

Created with Highcharts 6.0.6-2.5-2.50.20.2-0.7-0.70.10.1-0.2-0.2-0.5-0.52023Q22023Q32023Q42024Q12024Q22024Q3-3-2.5-2-1.5-1-0.500.5smart-lab.ru

Axsome Therapeutics. CAPEX/Revenue, changes, pp

Created with Highcharts 6.0.6-2.3-2.3-0.4-0.4-0.7-0.70.20.20.40.4-0.6-0.60.10.1-0.1-0.10.10.12022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-2.5-2-1.5-1-0.500.5smart-lab.ru